Showing 1561-1570 of 4065 results for "".
The Corticosteroid Journey in PMR: Understanding the Patient Experience
https://reachmd.com/programs/medical-industry-feature/pmr-corticosteroid-patient-experience/39774/Even though corticosteroids can bring quick, symptomatic relief for patients with polymyalgia rheumatica (PMR), their long-term use may be associated with adverse consequences.1-3 But adopting an individualized strategy and exploring alternative therapies can help empower patients to actively engageVitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
https://reachmd.com/programs/neurofrontiers/vitamin-d3-effects-on-inflammatory-and-oxidative-biomarkers-in-ms/54233/The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy
https://reachmd.com/programs/medical-industry-feature/the-role-of-april-and-the-4-hit-process-in-the-pathogenesis-of-iga-nephropathy/29539/TBDStudy Finds Diabetes in the United States Continues to Rise
https://reachmd.com/programs/the-jama-report/study-finds-diabetes-united-states-continues-rise/7696/[Read the Article] Twenty-nine million people in the United States have diabetes. If left untreated, diabetes can cause serious health-related complications. The total estimated cost of diabetes in the United States was $245 billion in 2012, which includes both health care costs and lost productivitTYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
https://reachmd.com/programs/dermconsult/tyk2-inhibition-with-zasocitinib-delivers-early-benefit-across-psa-domains/32812/AES Honors 2025 Award Recipients
https://reachmd.com/programs/practical-neurology/aes-honors-2025-award-recipients/49197/Myopia Control in Europe: The Case for Upfront Investment in Childhood
https://reachmd.com/programs/eye-on-ocular-health/myopia-control-in-europe-the-case-for-upfront-investment-in-childhood/36287/Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
https://reachmd.com/programs/project-oncology/stratifying-advanced-endometrial-cancer-real-world-outcomes-by-molecular-subtype/35509/A recent study published in the International Journal of Gynecological Cancer found that molecular subtype was a significant predictor of time-to-recurrence and cancer-specific survival in advanced endometrial cancer. Dive into the data and explore implications for tailoring patient care.The Science of Hair Aging: Why Hair Turns Gray, Thin, and Fragile
https://reachmd.com/ma-issues-index/may-jun-2026-issue/the-science-of-hair-aging-why-hair-turns-gray-thin-and-fragile/57932/Understanding the fundamentals is critical as hair restoration treatment options expand.The Science of Dual-Wavelength Photobiomodulation
https://reachmd.com/ma-issues-index/may-jun-2026-issue/the-science-of-dual-wavelength-photobiomodulation/57931/Adding a 620-nm wavelength to a 660-nm wavelength to stimulate nitric oxide release produces favorable clinical results.